Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Strides gains USFDA approval for Theophylline Extended-Release Tablets, 300 mg and 450 mg
Strides is eligible for 180 days of Competitive Generic Therapy (CGT) exclusivity for Theophylline Extended-Release Tablets, 300…
Immuneel Therapeutics welcomes Amit Mookim as CEO
Mookim will focus on establishing partnerships with providers, practitioners, and public health, and delivering current CART…
Dr Reddy’s receives EIR for API manufacturing facility
Inspection concluded at its API manufacturing facility in Srikakulam, Andhra Pradesh
Emcure launches Arth, aims to alleviate symptoms of menopause
The product range is developed to alleviate common menopause symptoms such as hot flashes, night sweats, mood swings, and vaginal…
PCIM&H recieves key ISO/SO IMS certifications
The certifications enhance PCIM&H's operational efficiency and support the Ministry of Ayush’s mission to promote high…
Indian Immunologicals unveils pediatric dose of indigenous Hepatitis A vaccine, Havisure
The Hepatitis A vaccine is available in both 0.5 ml and 1 ml dosage forms for pediatric and adult use, respectively
Alembic gains final USFDA approval for Albendazole Tablets USP, 200 mg
Albendazole tablets are indicated for the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms…
Parexel strengthens real world research offering
To lead this growing area of focus, Parexel has appointed Mike D’Ambrosio as Senior Vice President, Global Head, Real World…
Enzene appoints new site lead for flagship US continuous biomanufacturing facility
Stoffregen will take responsibility for Enzene’s global biologics business and lead the final stages of work to commission the…
NATCO Canada announces $ 8 mn investment in eGenesis
eGenesis is working on a genome engineering-based approach to the development of safe and effective transplantable organs with the…